SecBot SecBot
SECBOTREPLAY Home › Report › NVO

NVO · Protective order entered

NOVO NORDISK A S · COURT-RULING filed Nov 12, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 1/10

COURT-RULING filed Nov 12, 2026 at 19:00 ET

The court entered a stipulated protective order in Novo Nordisk's patent litigation against Mochi Health Corp., governing the handling of confidential information and trade secrets during discovery. This is a routine procedural step that does not resolve any substantive claims or impose any liability.

  • Novo Nordisk A/S and Novo Nordisk Inc. are plaintiffs in a patent infringement case against Mochi Health Corp., Mochi Medical CA P.C., and Mochi Medical P.A.
  • The case is pending in the Northern District of California, Case No. 5:25-cv-06563-EKL.
  • The court entered a stipulated protective order on November 13, 2026, governing the designation and handling of confidential and highly confidential information.
  • The protective order includes a prosecution bar restricting involvement in patent prosecution related to semaglutide or its analogs for one year after judgment or settlement.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access